358 related articles for article (PubMed ID: 27910776)
1. Molecular Pathology of Malignant Transformation of Oral Submucous Fibrosis.
Chattopadhyay A; Ray JG
J Environ Pathol Toxicol Oncol; 2016; 35(3):193-205. PubMed ID: 27910776
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects.
Ray JG; Ranganathan K; Chattopadhyay A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):200-9. PubMed ID: 27422418
[TBL] [Abstract][Full Text] [Related]
3. Oral submucous fibrosis: review on mechanisms of malignant transformation.
Ekanayaka RP; Tilakaratne WM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):192-9. PubMed ID: 27289264
[TBL] [Abstract][Full Text] [Related]
4. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of betel quid chewing, tobacco use (in the form of cigarette smoking), and alcohol consumption on the risk of malignant transformation of oral submucous fibrosis (OSF): a case-control study in Hunan Province, China.
Liu B; Shen M; Xiong J; Yuan Y; Wu X; Gao X; Xu J; Guo F; Jian X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):337-45. PubMed ID: 26130067
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms of Malignant Transformation of Oral Submucous Fibrosis by Different Betel Quid Constituents-Does Fibroblast Senescence Play a Role?
Zhang P; Chua NQE; Dang S; Davis A; Chong KW; Prime SS; Cirillo N
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163557
[TBL] [Abstract][Full Text] [Related]
7. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.
Auluck A; Rosin MP; Zhang L; Sumanth KN
J Can Dent Assoc; 2008 Oct; 74(8):735-40. PubMed ID: 18845065
[TBL] [Abstract][Full Text] [Related]
8. Oral submucous fibrosis: An update on pathophysiology of malignant transformation.
Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA
J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621
[TBL] [Abstract][Full Text] [Related]
9. The effects of chewing areca/betel quid with and without cigarette smoking on oral submucous fibrosis and oral mucosal lesions.
Yang YH; Lien YC; Ho PS; Chen CH; Chang JS; Cheng TC; Shieh TY
Oral Dis; 2005 Mar; 11(2):88-94. PubMed ID: 15752081
[TBL] [Abstract][Full Text] [Related]
10. Oral submucous fibrosis. The South African experience.
VanWyk CW
Indian J Dent Res; 1997; 8(2):39-45. PubMed ID: 9495135
[TBL] [Abstract][Full Text] [Related]
11. High risk of malignant transformation of oral submucous fibrosis in Pakistani females: A potential national disaster.
Mohiuddin S; Fatima N; Hosein S; Fatima N
J Pak Med Assoc; 2016 Nov; 66(11):1362-1366. PubMed ID: 27812049
[TBL] [Abstract][Full Text] [Related]
12. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.
Chiu CJ; Chang ML; Chiang CP; Hahn LJ; Hsieh LL; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):646-53. PubMed ID: 12101112
[TBL] [Abstract][Full Text] [Related]
13. Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China.
Zhou S; Guo F; Li L; Zhou Y; Lei Y; Hu Y; Su H; Chen X; Yin P; Jian X
Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1094-8. PubMed ID: 18684592
[TBL] [Abstract][Full Text] [Related]
14. Epithelial atrophy in oral submucous fibrosis is mediated by copper (II) and arecoline of areca nut.
Khan I; Pant I; Narra S; Radhesh R; Ranganathan K; Rao SG; Kondaiah P
J Cell Mol Med; 2015 Oct; 19(10):2397-412. PubMed ID: 26248978
[TBL] [Abstract][Full Text] [Related]
15. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan.
Lee CH; Ko YC; Huang HL; Chao YY; Tsai CC; Shieh TY; Lin LM
Br J Cancer; 2003 Feb; 88(3):366-72. PubMed ID: 12569378
[TBL] [Abstract][Full Text] [Related]
16. The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis.
Yanjia H; Xinchun J
Clin Chim Acta; 2007 Aug; 383(1-2):51-6. PubMed ID: 17537414
[TBL] [Abstract][Full Text] [Related]
17. Oral submucous fibrosis: review on aetiology and pathogenesis.
Tilakaratne WM; Klinikowski MF; Saku T; Peters TJ; Warnakulasuriya S
Oral Oncol; 2006 Jul; 42(6):561-8. PubMed ID: 16311067
[TBL] [Abstract][Full Text] [Related]
18. Oral submucous fibrosis. A review.
Cox SC; Walker DM
Aust Dent J; 1996 Oct; 41(5):294-9. PubMed ID: 8961601
[TBL] [Abstract][Full Text] [Related]
19. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
20. Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis.
Cirillo N; Duong PH; Er WT; Do CTN; De Silva MEH; Dong Y; Cheong SC; Sari EF; McCullough MJ; Zhang P; Prime SS
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
